Reuters attributed a quote about access and reimbursement to Lynn Watkins at Monday’s FDA hearing on psychedelic drugs. She didn’t say it. What she did say, in two minutes on the federal record, was about chronic pain, facilitated touch during dosing, and moving all five toes for the first time in nine years.
The post What Lynn Watkins Actually Told the FDA about Chronic Pain and Psychedelics appeared first on Psychedelics Today.
